health
Daewoong Pharmaceutical Presents Baseline Characteristics Of 104 Patients In Global Phase 2 Trial For IPF Drug Candidate 'Bersiporocin' At ERS 2026

(MENAFN - PR Newswire) 104 IPF patients enrolled in US and South Korea as global Phase 2 trial progresses toward completion Study includes both antifibrotic-treated and untreated patients; ...
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
Meet Jordic: The Unlikely Voice Of A Heart-Health Warning Men Need To Hear
Menafn
YR Fitness Plans To Expand One-Stop Gym Solutions With Design And Fit-Out Services
Menafn
Dr. Simon Ourian, Whose Patients Have Included Kim Kardashian And Adriana Lima, Launches 'Ask Dr. Ourian'
Menafn

Regentis Biomaterials And The Shift From Symptom Management To Structural Repair In Knee Cartilage Care
Menafn

Stucco Restoration At Hillsborough Nursing Center Brings A Beneficial Side Effect
Menafn